Resultado de búsqueda
22 de may. de 2024 · At Amgen, artificial intelligence (AI) is more than a technological advancement—it's a pivotal force transforming the future of biotechnology. “We're living through a ‘hinge moment,’ merging tech and biotech to revolutionize drug discovery and development, manufacturing and commercialization,” says David Reese, Amgen’s ...
- FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ...
Breakthrough DLL3-Targeting Therapy Regimen for a Major...
- Amgen's Global Impact: A Commitment to Bettering the World
Amgen has released a new report this week detailing its...
- FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ...
Hace 1 día · Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grievous illnesses. The Company focuses on human therapeutics and ...
Hace 21 horas · , opens new tab rare blood disorder treatment Soliris. Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. The approval comes with a black ...
16 de may. de 2024 · The drug tarlatamab, or Imdelltra, made by the company Amgen, tripled patients’ life expectancy, giving them a median survival of 14 months after they took the drug.
17 de may. de 2024 · 1. Los anticuerpos son muy abundantes en nuestro sistema inmune. Los anticuerpos son proteínas y tienen diferentes formas y tamaños. Los más conocidos son los anticuerpos IgG, que tienen forma de Y. Nuestro sistema inmune puede fabricar alrededor de 2.000 anticuerpos por segundo.